The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

William Pao

Departments of Medicine

Memorial Sloan-Kettering Cancer Center

1275 York Avenue

New York

USA

[email]@mskcc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Departments of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, USA. 2003 - 2006
  • Program in Cancer Biology and Genetics and the Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, USA. 2005

References

  1. Defining clinically relevant molecular subsets of lung cancer. Pao, W. Cancer Chemother. Pharmacol. (2006) [Pubmed]
  2. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. Pao, W., Wang, T.Y., Riely, G.J., Miller, V.A., Pan, Q., Ladanyi, M., Zakowski, M.F., Heelan, R.T., Kris, M.G., Varmus, H.E. PLoS Med. (2005) [Pubmed]
  3. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. Pao, W., Miller, V.A., Politi, K.A., Riely, G.J., Somwar, R., Zakowski, M.F., Kris, M.G., Varmus, H. PLoS Med. (2005) [Pubmed]
  4. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. Pao, W., Miller, V.A. J. Clin. Oncol. (2005) [Pubmed]
  5. 'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC). Pao, W., Miller, V.A., Kris, M.G. Semin. Cancer Biol. (2004) [Pubmed]
  6. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., Mardis, E., Kupfer, D., Wilson, R., Kris, M., Varmus, H. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  7. Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance. Pao, W., Klimstra, D.S., Fisher, G.H., Varmus, H.E. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
 
WikiGenes - Universities